StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) income statement

BNRNasdaqServices-Medical Laboratories
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$13.32+0.25 (+1.91%)

Close on Nov 19, 2026Market cap $145.00MP/E –Yield –

Burning Rock Biotech Ltd income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
74.7%
Operating margin
-10.2%
Net margin
-10.3%
Return on equity, FY2025
-9.9%

Financial strength

Current ratio
2.99
Debt to equity
0.00
Debt to assets
0.2%
Cash to current liabilities
193.7%

Valuation

P/E ratio
–
Price to sales
1.79
Price to book
1.81
Dividend yield
–

See a number that looks wrong?